RF

Robert Farrell

Robert Farrell


Sr. Vice President Finance & CAO



Professional Overview
Robert Farrell is an accomplished finance executive with over 15 years of experience in the biopharmaceutical industry. As the Sr. Vice President Finance & Chief Accounting Officer at Morphic Therapeutic, he brings a strong track record of financial leadership, strategic planning, and operational expertise to the organization.

Experience Summary

Current Role
In his current position at Morphic Therapeutic, Robert is responsible for overseeing all financial functions, including accounting, treasury, financial planning and analysis, and tax compliance. He plays a pivotal role in driving the company's financial strategy, ensuring accurate and timely reporting, and supporting the organization's long-term growth objectives. Under his leadership, Morphic Therapeutic has achieved significant milestones, including securing multiple strategic partnerships and advancing its innovative pipeline of drug candidates.

Career Progression
Prior to joining Morphic Therapeutic, Robert held senior finance roles at several prominent biopharmaceutical companies. As the VP of Finance and Administration at Genocea Biosciences, he played a key part in the company's successful IPO and subsequent capital raises. At Magen BioSciences, he served as the Sr. Director of Finance, contributing to the company's financial planning and analysis efforts. Earlier in his career, Robert held the position of Corporate Controller and Treasurer at Oscient Pharmaceuticals, where he was instrumental in managing the company's financial operations and treasury functions.

Academic Background
Robert holds a Bachelor of Science degree in Accounting from the University of Massachusetts, Amherst. He is a Certified Public Accountant (CPA) and has completed additional executive education programs in strategic financial management and leadership.

Areas of Expertise
  • Financial planning and analysis

  • Accounting and financial reporting

  • Treasury management and cash flow optimization

  • Strategic financial decision-making

  • Mergers, acquisitions, and capital markets transactions

  • Financial systems and process optimization

  • Cross-functional collaboration and team leadership


Professional Impact
Throughout his career, Robert has consistently demonstrated his ability to drive financial and operational excellence. At Morphic Therapeutic, he has been instrumental in securing multiple strategic partnerships, optimizing financial processes, and supporting the company's clinical development efforts. His contributions have been instrumental in Morphic Therapeutic's growth and the successful advancement of its innovative drug pipeline.

Conclusion
With his extensive finance expertise, proven track record of success, and strong strategic mindset, Robert Farrell is a valuable asset to Morphic Therapeutic and the biopharmaceutical industry as a whole. He is committed to leveraging his financial acumen and industry knowledge to support the company's ongoing success and create long-term value for its stakeholders.